Transcriptomic changes induced in one cell type by another mediate many biological processes in the brain and elsewhere; however, achieving artifact-free physical separation of cell types to study them is challenging and generally allows for analysis of only a single cell type. We describe an approach using a co-culture of distinct cell types from different species that enables physical cell sorting to be replaced by in silico RNA sequencing (RNA-seq) read sorting, which is possible because of evolutionary divergence of messenger RNA (mRNA) sequences. As an exemplary experiment, we describe the co-culture of purified neurons, astrocytes, and microglia from different species (12-14 d). We describe how to use our Python tool, Sargasso, to separate the reads from conventional RNA-seq according to species and to eliminate any artifacts borne of imperfect genome annotation (10 h). We show how this procedure, which requires no special skills beyond those that might normally be expected of wet lab and bioinformatics researchers, enables the simultaneous transcriptomic profiling of different cell types, revealing the distinct influence of microglia on astrocytic and neuronal transcriptomes under inflammatory conditions.
Introduction
Signaling between different cell types is central to the development and function of multicellular organisms. The secretion of factors such as cytokines, growth factors, and steroids enables paracrine and hormonal signaling to take place. In addition, membrane-anchored ligands, such as ephrins, semaphorins, notch ligands and several epidermal growth factors (EGFs), as well as interleukin and tumor necrosis factor family members, mediate contact-dependent juxtacrine signaling 1 . Intracellular signals transduced by the activated receptors of these ligands frequently induce changes in gene transcription that mediate the physiological or pathological response to that signal. Thus, understanding non-cell-autonomous influences on transcriptomes can illuminate diverse physiological processes. Furthermore, because the influences between two cell types are rarely unidirectional, it is valuable to be able to profile different cell types' transcriptomes simultaneously. This is a challenging undertaking using conventional techniques, which typically involve the dissociation of cultures or tissues into a single-cell suspension, followed by sequential separation of distinct cell types. Not only can physical dissociation and sorting induce gene expression artifacts, but separation requires distinct cell surface markers on each cell type and specific antibodies to them to enable their labeling. Known markers may not exist, and even if they do, physical cell sorting often suffers from a degree of impurity.
Development and overview of the protocol
In the brain, as in other tissues, multiple cell types coexist with highly specialized functions, and reciprocal signaling among these cells plays a key role in the organ's development and function. For example, although neuronal activity controls many processes taking place in the neurons themselves [2] [3] [4] [5] [6] , it can also influence the properties of astrocytes and oligodendrocytes 7, 8 . Conversely, astrocytes can respond to external oxidative stress by providing protective support to nearby neurons 4, [9] [10] [11] . In addition, astrocytes play key roles in neuronal development by signaling to neurons 12, 13 . Microglia also signal to and interact with neurons, both in development and in disease states, whereas
Comparison with other methods
The characterization of one cell type's transcriptome in a mixture of several different cell types poses technical challenges associated with the need to physically separate cell types before transcriptional analysis. This physical separation is typically performed either by immuno-sorting or FACS, relying on cell type-specific cell surface markers or fluorescent protein expression, which is not always practical. Moreover, both techniques are subject to off-target cell-type contamination and loss of material from delicate subcellular regions, which is also an issue for another potential approach to cell-sorting, laser capture microdissection 24, 25 . In our previous publication 7 , we assessed the disadvantages of imperfect physical separation by simulating a sorting process that achieved 95% purity. We 'contaminated' mouse astrocytic mRNA with mouse neuronal mRNA, then performed RNA-seq, finding that 863 genes were more than twofold more highly expressed in the contaminated sample than in a sample of pure astrocytes, and the expression levels of 216 genes were more than tenfold higher in the contaminated sample than in the pure 'control' sample 7 . An additional issue to be aware of is the aberrant induction of transcriptional responses due to the sorting process itself: tissue dissociation, FACS, and immunopanning all induce strong immediate early gene expression, which can confound or occlude genuine data 7, 24, 25 . For example, we found that the trypsin digestion required to create a single-cell suspension before implementing magnetic activated cell sorting (MACS) or FACS induced the expression of multiple genes, including Fos, Fosb, Nr4a2, and Ier2. Thus, the effects of a genuine signal or stimulation that results in the upregulation of these genes could be occluded by the induction of these genes within the control sample because of the dissociation process. The full MACS and FACS protocols induced the aforementioned genes even further. For example, the Fosb expression level increased more than eightfold as a consequence of FACS implementation and more than 16-fold as a consequence of MACS implementation 7 . It is possible to circumvent the need for physical cell sorting by using the cell type-specific expression of tagged ribosomes such as EGFP-L10a 26 , with the caveat that this approach identifies only ribosome-associated mRNAs. Importantly, it should be pointed out that this technique, much like the physical sorting techniques, tends to be suitable only for the analysis of one cell type in any one sample. Mixed-species RNA-seq offers a complementary approach to the techniques described above 7 . By avoiding the need to physically sort cells before RNA extraction, the artifacts and issues described above can be avoided. Moreover, there is no theoretical limit to the number of cell types that can be studied simultaneously.
We also note that other software tools, such as Disambiguate 27, 28 , can be used to separate mammalian RNA-seq data according to the species of origin. However, these tools were primarily developed to study xenografts of human tumors in mouse hosts, so their use is limited to separating data originating from two species. They are characterized by a single built-in balance between sensitivity and specificity that may not be appropriate when the species being separated are closely related to each other or a different filtering strategy is required. For example, Disambiguate implements a 'permissive' approach, in which obtaining the maximum number of reads assigned per species is prioritized over minimizing the mis-assignment of reads to the wrong species. Sargasso, on the other hand, enables RNA-seq data originating from more than two species to be effectively separated, even when those species are closely related. It also allows users to define the precision and recall level. Moreover, by using multiple processors, when they are available, Sargasso also permits fast execution of the analysis. Finally, it is user-friendly-in most cases, mapping and separation of all RNA-seq datasets can be completed with a single command-line invocation.
Level of expertise needed
The establishment and characterization of the mixed-species co-cultures described requires no special skills. Library preparation for RNA-seq also relies on standard kits and protocols, although both library preparation and sequencing are typically performed in an institutional or commercial nextgeneration sequencing facility. Application of the Sargasso workflow to the raw RNA-seq reads requires no specific skills beyond those required for conventional RNA-seq read mapping and differential gene expression analysis. Thus, any researcher or bioinformatics service provider with experience in such analyses will be able to apply the Sargasso workflow to his/her RNA-seq reads.
Limitations
We have used the Procedure reported below to successfully disambiguate reads of human, mouse, and rat origin. As long as the core principles discussed in the Experimental design section below are PROTOCOL NATURE PROTOCOLS adhered to, then, in theory, the protocol can be applied to any combination of species. However, specific combinations may require further considerations to be taken into account, particularly if species are close in evolutionary terms, leading to a substantial fraction of RNA-seq reads being discarded as ambiguous because of 100% cross-species conservation (Supplementary Results, Supplementary Fig. 4 ). Of note, for closely related species, it is, however, possible to estimate the extent to which each gene will lose reads because of the disambiguation process, using theoretical read sets covering the species' transcriptome (e.g., see Supplementary Fig. 1a of Hasel et al. 7 ). Moreover, it is even possible to apply a correction factor to the post-Sargasso FPKM values to compensate for the aforementioned estimated read loss. However, for a simple 'off-the-shelf' protocol, we recommend an evolutionary gap of~15 million years, if the accuracy of the FPKM values themselves is of high importance.
More generally, for the data to be useful, the species' genomes must have been sequenced with high accuracy, minimizing sequencing errors or gaps, particularly within genes; otherwise, spurious discrepancies between genome and read sequences may lead to reads being discarded or even attributed to the wrong species. In addition, substantial differences in genome sequence or annotation quality between the species used may result in reads being incorrectly assigned. In our experiments, we have found that the genomes of commonly used mammalian species (human, mouse, rat, cow and pig) have been sequenced to suitable accuracy. If other species with less-complete genomes are being used, the procedure below includes steps to determine which genes may be ignored because of incorrect assignment of reads arising from sequencing errors or gaps.
Factors relating to the RNA-sequencing procedure itself should also be assessed: the longer the reads that are sequenced, the more probable it is that they will span nucleotides that will permit disambiguation between species-by covering a region that is not 100% conserved between the species; in addition, the sequencing depth required may be high if a minority cell type is very sparse. Of note, in our example protocol implementation described below, we achieved data for the microglial transcriptome, which represents <10% of the total cell number, by increasing the overall read depth to 240 million.
A limitation of this approach is that cell types from different species will never coexist in any natural physiological situation, raising the question of the validity of any results obtained. Thus, an additional consideration to be made while interpreting the data is whether any transcriptional changes induced in one cell type by another are due to their being derived from different animal species. There is a balance between obtaining biologically relevant results, through the use of species that are evolutionarily close to each other, while still permitting separation of RNA-seq reads. Although maintaining this balance requires that the particular choices of species be informed by biological knowledge of the systems being studied, controls involving single-species data can also be applied to test the probable extent of any issues. For example, in our previous publication 7 , when separating RNA-seq data originating from mouse and rat (median evolutionary separation time of 16 million years 29 ), we showed, with both simulated and real RNA-seq data, that the great majority of mouse reads can be unambiguously assigned to the mouse (see Supplementary Fig. 1a ,b from Hasel et al. 7 ). Thus, separation of reads was achieved in two mammalian species in which functional conservation and interspecies compatibility of many ligand-receptor pairs are thought to be high. However, we wanted to further test whether genes induced by rat neuronal activity in mouse astrocytes might be due to their different species of origin. We analyzed the expression of the activityregulated astrocytic genes whose induction could be tracked in a single-species co-culture by virtue of their expression being more than ten times higher in astrocytes than in neurons (15 out of 56 genes). All genes were indeed induced in a single-species mouse neuron-astrocyte co-culture but not in a neuronal monoculture, which means that, with this subset of genes, there was no evidence that having neurons from a different species results in erroneous effects of synaptic activity on astrocytic gene expression (see Supplementary Fig. 6d from Hasel et al. 7 ). Other types of validation, such as immunohistochemistry 30 or translating ribosome affinity purification 26 , are possible for genes of particular interest.
A final caveat applies to any in vitro culture experiment: it is important to use the data to generate hypotheses as to the behavior of cells in vivo. An example can be found in the paper in which we first published this approach 7 . In that study, we were able to show that astrocytes in culture can be pushed toward a more in vivo-like phenotype by co-cultured neurons, that non-cellautonomous signaling maintains the expression of neuronally regulated astrocytic genes in vivo, and, finally, that neuronally controlled astrocytic genes selectively showed age-and disease-associated deregulation in vivo 7 .
Applications
The Procedure described below is centered on investigating the effect of non-cell-autonomous signaling on gene transcription among neurons, astrocytes, and microglia of mouse, human, and rat origin, respectively (Steps , in the presence and absence of a pro-inflammatory stimulus (LPS) that activates microglial Toll-like receptor 4 31 However, this particular stimulus could be replaced with any number of others designed to influence signaling in one or more of the aforementioned cell types, depending on the experimental question. Examples could include use of interleukin-13 to promote an anti-inflammatory microglial phenotype, a high K + solution to induce neuronal Ca 2+ influx, or tumor necrosis factor to promote a reactive astrocyte phenotype 18, 19, 32 . Moreover, the mixed-species RNA-seq workflow can be applied to any cell type or species combination, provided it is tailored to the experimental question or the practicalities of obtaining the cells that are required. In the context of biomedical research involving mammalian systems, the majority of cells used are of mouse, rat, or human origin. The use of these species is recommended, given their well-annotated genomes. There is no a priori reason why cell types of other species cannot be used, assuming they are separated evolutionarily by 15 million years or more. The steps described in the Procedure are applicable to all species combinations, and the controls described will ensure the data obtained by any species combination are reliable.
In terms of the cell types to be used, the Sargasso procedure can be used with any combination of cell types to suit the particular biological question. Clearly, a relevant biological question would probably involve the combination of cell types that are juxtaposed in a normal physiological situation. For example, other types of mixed-species co-culture experiments that are under way in our laboratory include the co-culture of human endothelial cells and mouse pericytes to study gene regulation associated with reciprocal signaling between these cell types. Moreover, the addition of rat microglia to these co-cultures, in the presence or absence of inflammatory stimuli, is being used to elucidate how signals associated with inflammatory insults influence the integrity of endothelial cell-pericyte monolayers.
Application of the procedure need not necessarily be restricted to in vitro preparations. We are also using this approach to probe the fate of xenotransplanted cells in vivo. The introduction of human wild-type and disease-associated induced pluripotent stem cell (iPSC)-derived neurons, astrocytes, and oligodendrocytes into the rodent brain is proving to be a valuable research tool [33] [34] [35] . We are using the Sargasso pipeline-based approach to profile both transplanted cells and 'host tissue' to improve our understanding of the development and maturation of the transplanted cells, as well as the host's response to the 'foreign' tissue.
We have also reported a different use of the Sargasso pipeline, namely, to study the expression of both human and mouse orthologs of the same gene in the same cell 32 . The cells used in this study (neurons) were obtained from the Tc1 mouse model of Down syndrome, in which mice carry a stably segregating extrachromosomal copy of human chromosome-21 36 . By using the Sargasso pipeline, followed by standard read mapping and DESeq2 differential gene expression analysis, we were able to study the activity-dependent regulation of human chromosome-21 genes, as well as their mouse orthologs, in the same cell, uncovering differences in the regulation of certain orthologs between human and mouse 32 . Other potential uses of mixed-species co-culture and the Sargasso pipeline include the study of the horizontal transfer of mRNA or miRNA from one cell to another, such as via exosomes 37 . Finally, although outside the scope of the current protocol, use of the Sargasso pipeline is not restricted to the separation of RNA-seq reads; it could be adapted to any nucleic acid sample studied by nextgeneration sequencing. A current area of development focuses on use of mixed-species co-culture, combined with chromatin immunoprecipitation sequencing (ChIP-seq) or short bisulfite sequencing, to elucidate the influence of one cell type on another's epigenome, such as in DNA methylation or histone modification.
Experimental design

Controls
Regardless of the biological question to be answered, several core principles should be adhered to in order to ensure the robustness of the data collected with the present protocol and the ability to draw reliable conclusions. First, the cell types to be studied must be characterized, ideally by immunohistochemistry, to confirm the presence of expected markers and the absence of markers of potentially contaminating cell types. As illustrated by the images reported in Fig. 1 , the neurons, astrocytes, and microglia from our example experiment are positive for their identifying markers (Neuro-Chrom, Gfap, and Iba1, respectively) and negative for each other's markers. Second, reference RNA-seq datasets must be generated (or be available from public databases) in which each cell type (or species) of interest is absent, but all other cell types (or species) in the full co-culture are present. These data are desirable to have in order to define the small number of genes whose reads from one species are attributed to the incorrect species' genome, either because of imperfect sequencing within the reference genome, polymorphisms in the precise genetic background of the animal from which the cells were derived, or failures in short RNA-seq read mapping (Steps 30-34). Although this misattribution problem affects only a small number of genes, it can by definition occur in differentially expressed genes when analyzing the influence that the presence of one cell type has on another's transcriptome. Ideally, such datasets will be generated for each experimental condition (for example, for each dose of a drug applied); this approach is desirable, as the set of genes expressed in each condition (and thus potentially the source of spurious read assignments) may not be fully encompassed by those expressed in the basal condition. We routinely disregard those genes in which mis-attributed reads are estimated to be >10% of the total number of reads. At this threshold, misattributed reads could falsely report an 11% induction of a gene's expression as a result of the presence of an additional cell type. In the Procedure below, we describe the generation of not only the neuron-astrocyte-microglia co-cultures, but also the two-species co-cultures of microglia-astrocytes, microglia-neurons, and astrocytes-neurons necessary to correct for any read mis-attribution. Their preparation follows the exact procedure for the triple culture, with the modification of simply leaving out one of the three cell types.
Sequencing depth
The final consideration to be made before implementing the Procedure is the depth of sequencing of the RNA-seq step (Step 23). Due consideration should be given to the desired depth with respect to the least abundant cell type in the co-culture mixture and/or the cell type contributing the least amount of RNA to the total mixed-species RNA pool, and the total sequencing depth should be scaled accordingly. The choice of the level of read depth should be made while also taking into account the fact that a proportion of reads will fail to be unambiguously mapped to any species because they are 100% conserved across two species or more, or because they do not reach one or more of the thresholds that have been imposed in order to achieve the required specificity of species assignment (e.g., the number of base mismatches allowed between read and genome, or the proportion of the read that is allowed to be left unmapped). The proportion of these 'unmapped' reads will depend on the evolutionary closeness of the species used, and it can be determined by applying the Sargasso workflow to an RNA-seq dataset from the individual species in question.
Materials
Biological materials
• Human primary astrocytes (Caltag Medsystems, cat. no. SC1800) • Mouse embryos (obtained from time-mated dams, from the institutional animal facility, or a commercial supplier such as Harlan or Charles River) ! CAUTION For experiments requiring animal tissue, appropriate national laws and institutional regulatory board guidelines must be followed. In the case of the experiment described here, all procedures were performed in compliance with the UK Animals (Scientific Procedures) Act 1986 (license P1351480E) and institutional regulations, and were approved by the University of Edinburgh Local Ethical Review Board.
• Rat pups (obtained from time-mated dams, from the institutional animal facility, or a commercial supplier such as Harlan or Charles River) ! CAUTION For experiments requiring animal tissue, appropriate national laws and institutional regulatory board guidelines must be followed. In the case of the experiment described here, all procedures were performed in compliance with the UK Animals (Scientific Procedures) Act 1986 (license P1351480E) and institutional regulations, and were approved by the University of Edinburgh Local Ethical Review Board.
Reagents
• Antibody (Gfap, 
Hardware
• Operating system: users of the protocol must have access to a Unix-like operating system, such as Linux or macOS, with a shell environment in which to execute commands, and the Python programming language (https://www.python.org) and Python package management system, pip (https://pip.pypa.io/), installed c CRITICAL All software was run on Ubuntu Linux 14.04.5 LTS. c CRITICAL The computing hardware used must be of sufficiently high specification to run all stages of the protocol; note, for example, that the STAR read aligner requires~30 Gb of RAM. c CRITICAL Unless otherwise stated, the commands listed in the protocol should be run within a terminal window. c CRITICAL Throughout this protocol, commands are indicated in Courier font, preceded by a '>' sign. Courier font is also used to indicate text file contents.
Software c CRITICAL Note that a bioinformatics researcher or service provider may have several, or all, of the required software and input file dependencies for the Sargasso pipeline already installed. Also, as the software tools are frequently updated, we suggest consulting the user manuals for compatibility; however, we do not foresee that any particular problem will arise if newer versions of these tools are used.
• Sargasso (https://github.com/statbio/Sargasso, https://doi.org/10.5281/zenodo.260123; also available as Sargasso-1. 41 Reagent setup c CRITICAL All reagents should be prepared in a sterile environment.
Cytosine β-D-arabinofuranoside (AraC, 240 mM stock) Dissolve 67.12 mg of AraC in 1 ml of sterile water. Store the resulting solution in 10-μl aliquots at −20°C for up to 6 months. Freshly dilute these 10-μl aliquots in 500 ml of NBA medium to prepare a 5.5 μM working concentration.
Human astrocyte culture Purchase primary human astrocytes at passage 1, then expand and maintain them according to the manufacturer's instructions. Dissociation medium for neuron and microglia culture (DM, 500 ml) Add 40.9 ml of sodium sulfate solution (1 M), 60 ml of potassium sulfate solution (0.25 M), 1.46 ml of magnesium chloride solution (2 M), 0.126 ml of calcium chloride solution (1 M), 0.5 ml of HEPES buffer (1 M), 1 ml of phenol red solution, and 4 ml of D-(+)-glucose solution (45% (wt/vol)); bring the total volume to 500 ml with sterile water. Filter the resulting mixture through a 0.22-μm filter and store the filtrate at 4°C for up to 1 month.
70% Ethanol (1,000 ml) Mix 700 ml of ethanol (absolute) with 300 ml of sterile water; store at room temperature (~18°C) indefinitely.
Kynurenic acid (5 mM stock, 160 ml) Add 158.56 mg of kynurenic acid to 5 ml of sterile water in a 50-ml Falcon tube, then add 0.4 ml of phenol red solution to the tube. Gradually (in~100-μl aliquots) add a total of 500 μl of 1 M sodium hydroxide solution, and extensively vortex (until the kynurenic acid is fully dissolved) the Falcon tube between aliquot additions. Add 0.4 ml of HEPES buffer (1 M) and 4 ml of 2 M magnesium chloride solution, and vortex. Transfer the resulting mixture to a 200-ml sterile bottle and adjust its volume to 160 ml using sterile water. Filter the mixture through a 0.22-μm filter and store the filtrate in 10-ml aliquots at −20°C for up to 6 months. c CRITICAL It takes time for kynurenic acid to dissolve completely. Be sure to add the sodium hydroxide gradually,~100 μl at a time, and vortex extensively. If the solution turns pink, do not add acid to adjust the pH; instead, discard and start again.
Dissection solution (100 ml) Pool together 36 ml of DM and 4 ml of kynurenic acid stock. Use 0.2 M sodium hydroxide solution to adjust the pH until the solution turns rose-red in color. The dissection solution should be made fresh each time.
D-MEM medium Add 50 ml of FBS and 5.5 ml of antibiotic-antimycotic to 500 ml of D-MEM. Sterile-filter using 500-ml filter cups and store the filtrate at 4°C for up to 7 d.
L-Glutamine (200 mM stock) Prepare 5-ml aliquots and store them at −20°C for up to 6 months. LPS (5 mg/ml stock) Dissolve 10 mg of LPS in 2 ml of sterile water. Store the resulting solution in 50-μl aliquots at −20°C for up to 6 months.
1% (vol/vol) Neurobasal-A-medium (1% NBA) Add 2 ml of antibiotic-antimycotic, 2 ml of rat serum, 4 ml of B-27 supplement, and 1 ml of L-glutamine stock solution to 191 ml of NBA. Sterile-filter through a 0.22-μm filter and store the filtrate at 4°C for up to 7 d. 0% (vol/vol) Neurobasal-A-medium (0% NBA) Add 2 ml of antibiotic-antimycotic, 4 ml of B-27 supplement, and 1 ml of L-glutamine stock solution to 193 ml of NBA. Sterile-filter and store the filtrate at 4°C for up to 7 d. Note that "0%" refers to the serum content.
OptiMEM I+ medium Add 4 ml of D-(+)-glucose solution (45% (wt/vol)) and 5 ml of antibiotic-antimycotic (100×) to 500 ml of OptiMEM I medium. Store the resulting solution at 4°C for up to 7 d.
PFA (4% (wt/vol), 1,000 ml) In a fume hood, add 40 g of sucrose to 1 liter of PBS in a glass bottle. Add a magnetic stir bar to the bottle, then heat the bottle on a hot plate at 55-60°C, making sure to keep the lid off. With the fume hood vent switched off, carefully measure out 40 g of PFA and add it to the heated solution while stirring its contents, then turn the hood back on. Once the PFA is fully dissolved, allow the mixture to cool to room temperature, remove any undissolved crystals by pouring the solution through filter paper, and store 50-ml aliquots of the filtrate at −20°C for up to 1 year. ! CAUTION PFA is toxic; all preparations involving PFA should be performed in a fume hood. c CRITICAL PFA powder should be added when the solution has been heated to 55-60°C. Make sure that the temperature does not exceed 65°C.
Papain dissociation solution (36,000 USP units per ml stock) Pool together 10 ml of kynurenic acid stock, 90 ml of DM, and 45 mg of L-cysteine. Add sodium hydroxide solution (0.2 M) to the resulting mixture until the solution turns rose-red in color. Add 120 mg of papain powder to the red solution, mix well, filter through a 0.22-μm filter, and store the filtrate in 10-ml aliquots at −20°C for up to 6 months.
Poly-D-lysine hydrobromide (1 mg ml −1 stock) Dissolve 50 mg of poly-D-lysine in 50 ml of sterile water. Store the resulting solution in 5-ml aliquots at −20°C for up to 6 months; once an aliquot has been thawed, store it at 4°C and use it within 1 week.
SGG medium (500 ml) Add 11.4 ml of sodium chloride solution (5 M), 14.6 ml of sodium bicarbonate solution (7.5% (wt/vol)), 0.882 ml of potassium chloride solution (3 M), 0.251 ml of magnesium chloride solution (2 M), 1 ml of calcium chloride solution (1 M), 5 ml of HEPES buffer (1 M), 0.5 ml of glycine (1 M), 6 ml of D-(+)-glucose solution (45% (wt/vol)), 2.5 ml of sodium pyruvate solution (0.1 M), and 1 ml of phenol red (0.5% (vol/vol)). Store the resulting solution at 4°C for up to 7 d.
TMo medium (500 ml) Pool together 445 ml of SGG medium, 50 ml of MEM (+Earle's, −glutamine), and 5 ml of antibiotic-antimycotic. Store the resulting solution at 4°C for up to 7 d.
Animal housing and maintenance
The pregnant mice and rats are housed with other female animals that become pregnant on the same day and then are housed individually a few days before the litters are born. The cages are checked twice a day, and the beddings are changed weekly. The food is SDS Rat and Mouse RM1 diet (maintenance diet). The enrichment includes tunnels, nesting materials, and chew sticks.
Equipment setup
Poly-D-lysine-coated 24-well plates or T75 flasks In a sterile hood, prepare a coating mix by adding 1.33 ml of poly-D-lysine stock to 100 ml of sterile water to prepare a working solution of 0.013 mg ml −1 . Add 0.4 ml of coating mix to each well of a 24-well tissue culture plate or 10 ml of coating solution to each T75 flask. Incubate the plates or flasks for 2 h at 37°C. Aspirate the coating mix from the plates or flasks, rinse the plates or flasks with sterile water, aspirate the water, and leave the plates or flasks in a sterile hood with the lid off until they are completely dry (~1 h).
c CRITICAL Be sure to wash the plates or flasks with sterile water rather than with PBS, as the latter forms crystals when it dries.
Installation of STAR and sambamba Download STAR from https://github.com/alexdobin/STAR and sambamba from https://github.com/ biod/sambamba. In both cases, pre-compiled executables are available for Linux and macOS.
Downloading and extraction of genome sequence and annotation files Download and extract the genome sequence and annotation files; directions on downloading genome information are given in Box 1.
Downloading of raw RNA-seq data to the server Raw RNA-seq data will be provided by your preferred sequencing facility. Alternatively, existing datasets can be downloaded from an online database, such as the NCBI Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) or the European Nucleotide Archive (https://www.ebi.ac.uk/ena). The data used in the Anticipated results section of this protocol can be downloaded from the European Nucleotide Archive (accession no. E-MTAB-5987, see https://www.ebi.ac.uk/arrayexpress/experiments/ E-MTAB-5987/).
Input file formats
The main input files supplied to Sargasso should be raw per-sample sequencing reads, as produced by a sequencing facility, in FASTQ format. These files are also assumed to have been gzip-compressed. Sargasso also requires genome sequence and annotation files for the species being separated. Genome sequences should be supplied in FASTA format; multiple reference sequences can be contained in the same FASTA file, or separate FASTA files can be provided for each reference sequence. Gene annotations should be supplied in GTF format. Refer to the STAR manual in regard to requirements for these files; in particular, the chromosome names in the annotation files must match those in the genome sequence files. In the example application of this protocol below, genome sequences and annotations from Ensembl v.86 (Yates et al. 42 ) were used.
Installation of virtualenv and virtualenvwrapper
Sargasso has a number of dependencies on other Python packages, and hence we strongly recommend (although it is not required) installing it in an isolated Python environment using the virtualenv (https://virtualenv.pypa.io) tool. In addition, the virtualenvwrapper (https://virtualenvwrapper. readthedocs.io) tool helps to manage multiple virtual environments. Install both tools using the Python package management system, pip, as shown below (see Troubleshooting section).
> pip install virtualenv > pip install virtualenvwrapper
We recommend following the virtualenvwrapper installation documentation to ensure that virtualenvwrapper functions correctly with the user's particular command-line shell (e.g., Bash).
Installation of Sargasso in a new Python virtual environment
Create a new virtual environment project directory called 'neurons_astrocytes_microglia' (or any other appropriate name of the user's choice), and then install Sargasso using pip as shown below.
> mkproject neurons_astrocytes_microglia > pip install git+https://github.com/statbio/sargasso.git Procedure c CRITICAL The culture of microglia (Steps 1-9), astrocytes (Steps 10-15), and neurons (Steps 16-18) are described sequentially below, but have overlapping timelines. Throughout the Procedure, each day is numbered relative to the first day of Step 1.
Rat microglia culture • Timing 12-14 d
1 On day 1, take 10-12 rat pups of post-natal day 0-2, dislocate the necks with forceps and decapitate them with scissors. This number is needed to reliably produce the microglia required and is kept to a minimum according to ARRIVE principles. Keep the heads in a Petri dish containing freshly prepared dissection solution. Stabilize the head with a pair of fine needles, make a horizontal slit in the skin with fine scissors, and then cut up along the midline. Cut the skull along the midline while pulling up with scissors; make horizontal incisions on each side, at the bottom, and at the top. Using forceps, open the skull to reveal the brain, scoop out the brain from underneath, and then leave it in a Petri dish containing dissection solution. Under a dissection microscope, cut off the olfactory bulbs and, using forceps, peel the cortical hemispheres away from the hindbrain and thalamus. ! CAUTION For experiments requiring animal tissue, appropriate national laws and institutional regulatory board guidelines must be followed. In the case of the experiment described here, all procedures were performed in compliance with the UK Animals (Scientific Procedures) Act 1986 (license P1351480E) and institutional regulations, and were approved by the University of Edinburgh Local Ethical Review Board. c CRITICAL STEP To preserve the brains, make sure they are fully submerged in the dissection solution, and agitate the Petri dish occasionally to equilibrate the medium. 2 To begin the enzymatic dissociation, warm the papain dissociation solution in a 37°C water bath.
Transfer six to eight cortical hemispheres to one polystyrene round-bottom tube, and add 2 ml of papain dissociation solution to each tube. Leave the tubes in a 37°C water bath for 20 min and carefully shake them every 5 min. After 20 min of incubation, aspirate the solution and replace it with fresh papain dissociation solution. Incubate for another 20 min and carefully shake the tubes every 5 min. 3 Remove the papain dissociation solution and wash the brains twice with 2 ml of dissection solution.
Between washings, hold each tube horizontally and rotate slowly while rocking it back and forth to wash the enzyme off the walls and agitate the meninges away from the cortical hemispheres. Remove the dissection solution, wash the cortical hemispheres twice with 2 ml of pre-warmed (37°C) 1% (vol/vol) NBA, and leave them in pre-warmed (37°C) 1% (vol/vol) NBA medium to proceed to Step 4. 4 Take two 15-ml Falcon tubes (label them A and B) for every six to eight cortical hemispheres and add 10 ml of 1% (vol/vol) NBA medium to tube A. Remove the NBA solution from the polystyrene round-bottom tube that contains the cortical hemispheres from Step 3, and, using a 5-ml pipette, take 2 ml of 1% (vol/vol) NBA medium from tube A and add it to the brain tissues contained in the polystyrene round-bottom tube. Pipette up and down quickly 50-60 times (taking care not to let the pipette tip touch the bottom of the tube) and add another 2 ml of 1% (vol/vol) NBA from tube A to the round-bottom tube. Leave the round-bottom tube to rest for 2 min for all the debris to settle. Single cells will remain in the supernatant. 5 Repeat Step 4 for all the other cortical hemisphere samples. 6 Remove the supernatant (4 ml) from the polystyrene round-bottom tubes very gently, without touching the tissue at the bottom of the tube, and transfer it to one of the empty 15-ml Falcon tubes (tube B) from Step 4. 7 Add another 4 ml of 1% (vol/vol) NBA from tube A to each polystyrene round-bottom tube (which leaves 2 ml of 1% (vol/vol) NBA in tube A), pipette up and down quickly 50-60 times (taking care not to let the pipette tip touch the bottom of the tube), and leave the tubes to rest for 2 min for all the debris to settle. Remove the supernatant (4 ml) from the polystyrene round-bottom tubes very gently, without touching the tissue at the bottom of the tube, and transfer it to tube B. Take the remaining 2 ml of 1% (vol/vol) NBA and vigorously dissociate the remaining tissue in the roundbottom tube, pipetting up and down 50-60 times with the pipette tip pushed to the bottom of the tube. Leave the contents to settle for 5 min and transfer this last 2 ml of cell suspension to tube B (making 10 ml in total). 8 To plate, collect the homogenized cell suspension from all the B-labeled 15-ml Falcon tubes prepared in Steps 6 and 7, and transfer it to a single sterile bottle. Using pre-warmed (37°C) OptiMEM I+ medium, adjust the volume of this mixture to 100 ml. Mix by pipetting up and down with a 25-ml pipette. Plate 10 ml of the cell suspension in a poly-D-lysine-coated T75 flask. Allow the cells to settle for 2.5 h in an incubator (37°C, 5% CO 2 ). c CRITICAL STEP Be sure that the cells are mixed well before plating them. For this purpose, homogenize the diluted mixture by quickly pipetting up and down with a 25-ml pipette, but avoid excessive swirling, which causes an uneven distribution of cells in solution. 
Human astrocyte culture • Timing 3-4 d
10 On day 2, i.e., the day after the start of microglia culture (Step 1), take a vial containing~1 million frozen primary human astrocytes stored at −80°C and thaw its contents rapidly in a 37°C water bath. Spray the vial with 70% (vol/vol) ethanol and, using a 5-ml plastic pipette, gently transfer the cells to a poly-D-lysine-coated T75 flask containing 15 ml of pre-warmed (37°C) astrocyte medium. Allow the cells to settle for at least 12 h. ? TROUBLESHOOTING 11 On day 3, aspirate the medium from the T75 flask, gently wash the bottom of the flask with 10 ml of 1XDPBS, aspirate the DPBS, and add 4-5 ml of pre-warmed (37°C) trypsin-EDTA to the flask. c CRITICAL STEP Be sure to wash away the residual astrocyte medium with DPBS, as the serum present in DPBS medium can inhibit trypsin activity. 12 Place the flask in a 37°C incubator for 3-5 min or until all the cells have rounded up. 13 Remove the flask from the incubator and gently tap its sides to force the cells to detach from the flask surface. Check under a microscope to make sure that all the astrocytes are detached. Add 10 ml of D-MEM medium to the flask and wash all the remaining astrocytes from the surface. 14 Use a pipette to transfer all the medium from the flask to a 15-ml Falcon tube, then centrifuge the tube at 150g for 4 min at room temperature. 15 Aspirate the supernatant from the Falcon tube, add 1 ml of astrocyte medium to the pellet and resuspend the pellet using a 1-ml pipette. Count the cells and plate them at a density of 30,000-50,000 cells per well in astrocyte medium on a poly-D-lysine-coated 24-well plate. The number of wells required is four per condition per culture type. Allocate astrocyte wells for the generation of the three-species co-culture, as well as for the two-species neuron-astrocyte and microglia-astrocyte co-cultures. Leave the cells to grow for 1-3 d until they reach 80-90% confluency. c CRITICAL STEP Before each passage, use a standard tissue culture microscope under phase contrast to check for any obvious changes in human astrocyte morphology. The key change visible in late-passage astrocytes is a loss of processes, which is why we recommend using only astrocytes that have been passaged ≤4 times. j PAUSE POINT Human astrocytes can be passaged up to four times before co-culturing them with mouse neurons. To passage the cells, take a confluent T75 flask of astrocytes, follow Steps 11-14, and then resuspend the cell pellet and plate them onto three T75 flasks in astrocyte medium (20 ml per flask).
Mouse neuron co-culture with astrocytes • Timing 7-8 d
16 On day 5, take two or three mouse embryos of embryonic day 17.5, dissect them, and dissociate the cortical hemispheres as described in Steps 1-7. This number is needed to reliably produce the neurons required and is kept to a minimum according to ARRIVE principles. 17 Collect the homogenized cell suspension from the 15-ml Falcon tubes into a sterile bottle and, using pre-warmed (37°C) OptiMEM I+ medium, adjust the suspension's volume to 28 ml per embryo. Remove the medium from the human astrocytes from Step 15, mix the neuron suspension well with a 25-ml pipette, and plate 0.5 ml of the mouse neuron cell suspension into wells containing human astrocytes. Plate four wells per condition, per co-culture type, and allocate half of the wells to the three-species co-culture (to which microglia are added, see below) and half to the two-species astrocyte-neuron co-culture (no microglia). Ensure that a set of astrocyte-containing wells are left without neurons plated onto them for the generation of two-species microglia-astrocyte co-culture. In addition, plate neurons onto poly-D-lysine-coated 24-well plates (no astrocytes) for the generation of two-species microglia-neuron co-culture, again at four wells per condition. The density of mouse neurons should be 9-13 × 10 4 cells per well. Leave the plates for 2.5 h in a 37°C tissue culture incubator. ? TROUBLESHOOTING 20 Remove the culture medium containing the microglia and transfer it to a fresh tube, then centrifuge at 150g for 5 min at room temperature. Remove the supernatant and re-suspend the pellet in 2 ml of NBA medium without serum (0% (vol/vol) NBA). Count the cells with a hemocytometer. The yield is typically 5-15 million cells. Adjust the concentration to 2 × 10 5 cells per ml in 0% (vol/vol) NBA. Remove the medium from the neuron-astrocyte co-culture from Step 18 and plate 1 ml of the microglia suspension into each well that is intended for three-species co-culture. Repeat the process with the astrocyte-only and neuron-only culture wells to create the two-species neuron-microglia and astrocyte-microglia cultures, respectively, which are maintained under the same conditions as the three-species co-culture, i.e., 37°C, 5% CO 2 . 21 (Optional) If desired, perform immunostaining for neurons, astrocytes, or microglia with antibodies targeting appropriate cell-type markers, for example, Neuro-chrome, Gfap, or Iba1. This may be useful if experimenters wish to confirm the identity of their cell type and rule out the presence of other cell types in their preparation. The co-cultures should be fixed for immunostaining 1-3 d after microglial plating (i.e., days [13] [14] [15] by replacing the medium with 300 µl of PFA per well, leaving the co-cultures at room temperature for 10-20 min, and then washing them three times with PBS, after which a standard immunostaining protocol should be followed 43 . 22 To subject the cells to an inflammatory challenge, on day 16 (if the microglia are collected and plated on day 13), replace the medium with TMo medium. Then on day 17, challenge the co-cultures with an inflammatory stimulus, for instance, by adding 10 µl of LPS stock (5 mg/ml) to each well for a final concentration of 50 µg/ml. c CRITICAL STEP In the case described, the challenge to which the cells were subjected is inflammatory in nature; however, the cells may, of course, be subjected to other types of challenges (see Introduction). 23 On day 18, collect the total RNA and test the RNA integrity by standard methods. In our laboratory, we use the Roche RNA Isolation Kit, implementing the standard protocol, and then confirming the quality of total RNA by measuring the RNA integrity number (RIN) on RNA 6000 Nano Chips in the Agilent 2100 Bioanalyzer by following the manufacturer's instructions. After you have established the RNA integrity, submit the RNA to your preferred facility for conventional RNA-seq at an appropriate depth (see Experimental design).
? TROUBLESHOOTING
In silico separation of RNA-seq reads with Sargasso • Timing~7 h 24 In the virtual environment project directory, construct a tab-separated file listing the raw RNA-seq read data files for each sample in the experiment. Each line in the file should correspond to a single RNA-seq sample. In the case of paired-end reads, each line should contain three columns: a sample name, and then two comma-separated lists of the gzipped FASTQ files that contain the first and second mates of the paired-end RNA-seq reads for that sample. In the case of single-end reads, each line should contain two columns: a sample name and a comma-separated list of the gzipped FASTQ files containing reads for that sample. For example, if our first sample has the name SAMPLE_A, the raw-read FASTQ files for this sample are contained in the directory '~/sargasso_data/sample_a', and there are three pairs of paired-end read files for this sample (denoted 'sample_a1', 'sample_a2', and 'sample_a3'). The first line of our samples file, 'samples.tsv', would then read: SAMPLE_A sample_a/sample_a1_1.fastq.gz,sample_a/sample_a2_1.fastq.gz,sample_a/sample_a3_1.fastq.gz sample_a/sample_a1_2.fastq.gz,sample_a/sample_a2_2.fastq.gz,sample_a/sample_a3_2.fastq.gz 25 Run the Sargasso pipeline to map and separate the per-sample raw RNA-seq reads according to their true species of origin. As discussed previously, Sargasso enables the user to control the balance between sensitivity and specificity when separating reads, via a number of thresholds that the mapped reads must pass; these thresholds are controlled through the command-line options --mismatch-threshold, --minmatch-threshold, --multimap-threshold, --overhang-threshold, and --reject-multimaps. Sargasso also provides a number of 'pre-baked' filtering strategies that specify particular values for these options and thus different balances between sensitivity and specificity. As an exemplary application of this protocol, here we use a pre-baked 'conservative' strategy, in which minimizing the number of reads mis-assigned to the wrong species takes the foremost priority, rather than recall of the maximum number of reads per species. In the 'neurons_astrocytes_microglia' virtual environment project directory previously created (see Equipment setup), execute:
> species_separator --num-threads=16 --reads-base-dir=/home/sargasso_user/sargasso_data/ --conservative --run-separation samples. tsv sargasso_output human /home/sargasso_user/sargasso_data/Homo_sa-piens.GRCh38.86.gtf,/home/sargasso_user/sargasso_data/human_pri-mary_assembly mouse /home/sargasso_user/sargasso_data/Mus_musculus. GRCm38.86.gtf,/home/sargasso_user/sargasso_data/mouse_primary_as-sembly rat /home/sargasso_user/sargasso_data/Rattus_norvegicus. Rnor_6.0.86.gtf,/home/sargasso_user/sargasso_data/rat_toplevel
The --num-threads=16 option indicates that 16 processor cores should be used at any stage of the separation procedure that can be multi-threaded (note that although the Sargasso pipeline can be run with any number of threads, increasing the number of processing cores used will reduce execution time). The --reads-base-dir option allows a base directory to be set for RNA-seq data input files, which can simplify construction of the samples file 'samples.tsv'. The --runseparation option indicates that the separation pipeline will be executed immediately in the background via the nohup command; execution can, alternatively, be postponed until a later time by omitting this option, particularly if further fine-grained alterations of the separation procedure are necessary. Here, we have also assumed that the samples file 'samples.tsv' has been written into the virtual environment project directory. The Sargasso output will be written into the 'sargasso_output' directory, which will also be created in the project directory; pipeline progress can be monitored by examining the file 'nohup.out', which is written into the 'sargasso_output' directory. c CRITICAL STEP Note that here we have specified the genome sequence and annotation files for each species; thus, in this case, the first step executed by the Sargasso pipeline will be to build STAR indices for each genome. In subsequent pipeline runs, these pre-built STAR indices can be reused to reduce execution time.
Examination of the Sargasso output • Timing 30 min
26 On completion of the Sargasso pipeline, ensure that the 'sargasso_output' directory contains the following subdirectories: 'star_indices', which contains a STAR index directory for each species' genome; 'raw_reads', which contains symbolic links to the gzip-ped FASTQ files for each sample; 'mapped_reads', which contains a BAM (Binary Alignment Map) file for each sample and species describing the mapping of the RNA-seq reads in that sample to the species' genome (whatever the true species of origin of those reads is; note that this subdirectory also holds log files output by STAR containing statistics describing its performance); 'sorted_reads', which contains a BAM file for each sample and species, in which the mapped reads above have been sorted in name order; and 'filtered_reads', which contains a BAM file for each sample and species, describing the mapping of the RNA-seq reads determined to have originated from that species to that species' genome. c CRITICAL STEP If Sargasso has been run with the --run-separation option, the 'sargasso_output' directory will also contain a file, 'nohup.out', which records the commands executed during pipeline operation and their terminal output. In the case that any of the directories listed above do not contain the expected files on completion of the pipeline, 'nohup.out' can be examined to pinpoint the source of any errors. ? TROUBLESHOOTING 27 Ensure that two further log files are written after completion of the Sargasso pipeline. In the 'filtered_reads' directory, 'overall_filtering_summary.txt' contains per-sample statistics describing the number of reads that were assigned to each genome or that were rejected as not belonging to that species or as ambiguous. In the top-level output directory, 'execution_record.txt' contains a record of the command-line options that were passed to Sargasso, together with the date and time of execution.
Downstream analysis • Timing variable according to the analysis performed
28 For each RNA-seq sample, the Sargasso pipeline's output consists of per-species BAM files describing the mapping of reads determined to have originated from those species. These BAM files can then be used as the input of any standard post-mapping RNA-seq analysis. Notably, no peculiarities are expected to occur in such analyses because of the processing by Sargasso. One possible downstream analysis would be to determine the differential gene expression for a particular cell type. To perform this type of analysis, count the reads assigned to each gene in each sample for the appropriate species by using each BAM file as input for a read-counting tool such as featureCounts 44 . 29 Use the per-sample read count files produced by featureCounts as output to detect genes whose expression has changed in a statistically significant manner, using tools such as DESeq2 45 or edgeR 46 . Briefly, to calculate differential gene expression with DESeq2, first install the DESeq2 package within the R programming environment (the DESeq2 package is part of Bioconductor, an open-source repository for tools for the analysis of high-throughput genomic data: https://bioconductor.org). Using the per-sample read count files produced by featureCounts as input, construct a table in R containing all per-gene read counts for all samples. In addition, construct a second table containing metadata describing the grouping of the samples, most importantly indicating which experimental condition is distinctive of each sample. These tables, together with a model formula describing how gene expression is believed to depend on the experimental groupings of samples, form the input to the main DESeq2 functions, which perform library-size normalization of per-gene read counts across samples, estimation of per-gene count variances, and statistical tests for per-gene differences in counts between experimental conditions, using the negative binomial distribution. Finally, for any experimental condition of interest, extract the lists of genes expressed at significantly different levels, together with the relevant P values and fold changes in expression. Notably, a similar workflow would be used if, instead of the DESeq2 package, the reader were to use the edgeR package or some other differential expression tool; for more details on such standard differential gene expression processing, see, for example, Anders et al. 47 Further steps, to avoid misinterpretation of data • Timing 2 h c CRITICAL When separating mixed-species RNA-seq data according to true species of origin, it is difficult to avoid making a small number of incorrect species assignments, and it is important to ensure that these reads do not lead to spurious conclusions. The approaches needed to avoid such misinterpretation may vary according to the particular downstream analysis that has been performed; in the present subsection of the procedure, as an illustration, we will provide instructions on how to implement one such possible approach when the objective of the approach is to determine differential gene expression. c CRITICAL Note that the calculations described below could be executed in any number of computational environments, for example, in an Excel spreadsheet or within the R programming environment. 30 Use the read counts that have been calculated for each species contained in the three-species co-culture samples, and also for each species in the two-species co-culture samples that do not contain one particular cell type, to determine the small number of genes that should be disregarded because of mis-attribution of reads to the wrong species. We illustrate here the case of gene induction in microglia by LPS in the presence of neurons and astrocytes; here, we must avoid misidentifying increased expression of rat microglial genes due to incorrect assignment of reads truly originating from mouse neuronal and human astrocytic genes, including from those mouse and human genes themselves induced by the presence of the perturbed microglia (similar steps should be carried out to avoid misidentifying mouse neuronal genes induced by perturbed microglia in the presence of human astrocytes, and human astrocytic genes induced by perturbed microglia in the presence of mouse neurons). First, calculate for each rat gene an approximate gene 'expression' in samples containing only mouse and human biological material, measured in fragments per kilobase per million mapped reads (FPKM), with the formula:
where c i is the number of reads assigned to rat gene i in the mouse plus human samples, l i is the length of the longest transcript of rat gene i, and R is the total number of reads assigned to all genes of all species in the mouse plus human samples. Note that if featureCounts has been used to count the reads assigned to genomic features, these read numbers can easily be extracted from the count summary files output.
31 For each rat gene, and for each three-species sample, calculate an approximate level of gene expression in the sample, measured in FPKM, with the same formula provided in Step 30:
where c i is now the number of reads assigned to the rat gene i in the three-species sample (after the sample has undergone species separation) and R is now the total number of reads assigned to all rat genes in the sample. 32 For each three-species sample, calculate the approximate ratio of 'mouse plus human' to rat RNA in the sample. To perform this task, examine the Sargasso log file, 'overall_filtering_summary.txt'. The fields with headers reading 'Filtered-Reads-Sn' give the number of input reads that were assigned to the nth species after species separation, in which the species are numbered in the order that they were specified on the command line in Step 25. Dividing the sum of these numbers for all species except one by the number for that species, gives the approximate ratio of RNA of all the other species compared with that one; in the present case, dividing the sum of 'Filtered-Reads' values for mouse and human by the value for rat gives the approximate ratio of 'mouse plus human' to rat RNA. Then calculate a mean ratio of 'mouse plus human' to rat RNA across all three-species samples. 33 For each two-species sample, calculate, for each rat gene, the percentage, p i , of that gene's expression that probably arose from mouse or human reads mis-assigned to the rat genome: ). The number of genes included in this category is probably small. c CRITICAL STEP Note that the exact subset of mixed-species samples used in this calculation must be chosen according to the differential expression comparison that is being made. In the example of microglial genes induced or repressed by LPS in the presence of neurons and astrocytes, the objective of this step is to avoid reads actually originating from mouse and human genes-whose own expression may have been upregulated or downregulated as a result of being co-cultured with microglia in the presence of LPS-being mis-interpreted as indicating increases or decreases in the expression level of rat microglial genes. In the case of upregulation, the mixed-species samples used to calculate the mean value of p i should be those in which LPS had been applied, whereas in the case of downregulation, the control condition mixed-species samples should be used to calculate the mean value of p i (note that in both cases, spurious assignment of human and mouse reads in the samples from the alternative condition might cause genes whose expression has truly changed as a consequence of the presence of LPS to not be recognized as having been differentially expressed, but it cannot lead to false differential expression calls).
Troubleshooting
Troubleshooting advice can be found in Table 1 . 
Timing
Steps 1-7, dissection and dissociation of rat and mouse cortices: 2-3 h
Step 8, plating of rat cortical cells: 3 h
Step 9, maintenance and maturation of cultured microglia : 11.75-13.75 d
Step 10, recovery of human astrocytes: 1-2 h Steps 11-15, passaging, plating, and culture of human astrocytes: 3-4 d
Step 16, culture of mouse neurons: 2-3 h Steps 17 and 18, co-culture of mouse neurons with human astrocytes: 7-8 d Steps 19 and 20, harvest and co-culture of microglia with mouse neurons and human astrocytes: 2-3 h
Step 21, immunostaining (optional): 2 d
Step 22, culture and inflammatory challenge: 5 d
Step 23, harvest of RNA and RNA quality control: 3-4 h
Step 24, preparation for in silico read separation: 30 min
Step 25, in silico read separation with Sargasso: 6.5 h Steps 26 and 27, examination of the Sargasso output: 30 min Step 25) is approximate, as the execution time depends on the exact nature of the computing hardware available to the user, the number and identity of species being separated, the number of samples being processed, and the depth to which sequencing was performed. In the actual experiment, the timing information provided was based on the use of 16 2.3-GHz processing cores, using a mixed mouse, rat, and human RNA-seq sample containing~240 million 75-bp paired-end reads; in this case, the execution time was 6.5 h (a rate of~36 million reads processed per h). Note that, of this time,~2/3 was taken up by the mapping of reads to the three genomes with STAR. Increasing (or decreasing) the number of species to be separated will decrease (or increase) the rate at which samples are separated, as will decreasing or increasing the number of processing cores that are allocated.
Anticipated results
We outline below the results of the analyses we performed in an example experiment designed to illustrate how it is possible to identify the transcriptional changes induced in neurons and in astrocytes by microglia, either unchallenged or activated by LPS (500 ng/ml) for 16 h, which triggers Toll-like receptor 4 signaling. This follows a three-species read separation (rat/mouse/neuron) that when used in Sargasso leads to accurate FPKM and fold-induction values (Supplementary Results, Supplementary Figs. 1-3 ). This application of the protocol enables microglia-dependent transcriptional changes to be tracked in both other cell types simultaneously. It also provides the means to determine the LPS-activated response of the microglia themselves. As noted above, the application differs from the previous published use of this protocol, which involved the use of just two cell types 7 . However, the inclusion of a third cell type, although it modifies the length of the Procedure, involves no conceptual changes to the workflow, nor does it impact the results obtained. The experimental conditions and co-culture composition of the samples are described in Table 2 . Figure 2a shows the overall proportion of reads within the three-species co-culture in sample sets 2a and 2b that are attributable to the three different cell types. Using the rat (microglia) reads, it is possible to identify the transcriptional changes that microglia themselves undergo in response to LPS, by comparing rat reads within the sample sets from 2a with those from 2b (see Table 2 for sample details). As expected, large numbers of genes were induced and repressed by LPS (Fig. 2b) . By mapping the rat-microglia-free astrocyte-neuron co-culture reads (LPS-treated, 1b samples (Table 2) ) against the rat genome, LPS-regulated genes with a >10% contribution from erroneous mapping from other species can be identified. In this example, only 14 out of the 1,430 LPS-repressed genes (>1.5-fold repressed, i.e., >33% reduction) and none of the 1,075 induced genes (>1.5-fold increased) were identified as erroneously mapped from other species and discarded from the final scatter plot (Fig. 2b) . Induced genes included well-known LPS/TLR4-inducible cytokine/chemokine genes Cxcl1, Cxcl2, Cxcl3, Ccl3, Il1a, and Il1b (Fig. 2b) . Among the genes repressed was the anti-inflammatory marker Igf1. Using co-cultures of microglia, neurons, and astrocytes from single species, we confirmed as far as possible that the LPS-induced microglial genes observed to be up-and downregulated Fig. 2 | Differential gene expression in microglia, astrocytes, and neurons in co-culture. a, For both the three-species co-culture (mouse neurons, human astrocytes, and rat microglia, right) and the mouse neuron-human astrocyte two-species co-culture (left), the number of reads unambiguously mapped to each species is shown, expressed as a percentage of the total number of unambiguously mapped reads of all species (n = 3 biological replicates, defined (here and throughout the article) as utilizing primary tissue from distinct animals). For the two-species co-culture samples, 64.1 ± 2.5 million reads per sample were unambiguously mapped, and for the three-species co-culture samples, 133.7 ± 12.5 million reads per sample were unambiguously mapped. Error bars represent the s.e.m. b, LPS-induced microglial gene expression. Species-specific read sorting identified rat (i.e., microglial) reads. Expression of genes (FPKM) in microglia ± LPS is plotted for the genes that expressed >0.5 FPKM, averaged over the conditions. Red crosses indicate the microglial genes whose expression level was modified by LPS presence >1.5-fold (DESeq2 P adj <0.05, n = 3 biological replicates, 1,075 genes induced, 1,416 genes repressed (14 of the initial 1,430 genes called as being significantly changed were discarded because of erroneous mapping)). Gray data points indicate the genes whose expression-level modification falls below these thresholds. c,d, Microglia-dependent transcriptional changes induced in astrocytes. Either three-species or two-species (lacking microglia) co-cultures were treated with LPS, and RNA-seq was performed. Species-specific read sorting identified human (i.e., astrocyte) reads. Expression of genes (FPKM) in the astrocytes in the presence of neurons only (two-species co-culture, x axis) is plotted against gene expression in astrocytes when microglia were also present (three-species coculture, y axis). Genes significantly altered in their level of expression by the presence of microglia are marked by red crosses (DESeq2 P adj <0.05, n = 3). c, basal conditions; d, LPS-treated cultures (1,039 genes induced, 474 genes repressed (3 of the initial 477 genes called as being significantly changed were discarded because of erroneous mapping)). e,f, Microglia-dependent transcriptional changes induced in neurons. The same samples as in c,d were used, and species-specific read sorting was used to identify mouse (neuronal) reads. Genes significantly altered by the presence of microglia are marked by red crosses (DESeq2 P adj <0.05, n = 3). e, basal conditions; f, LPS-treated cultures (430 genes induced, 9 genes repressed). Astr Hum , human astrocyte; astro-neuro-micro, astrocyte-neuron-microglia; Mic Rat , rat microglia; Neur Mus , mouse neuron.
in the presence of neurons and astrocytes were not due to the neurons and astrocytes being from a different species than the microglia (Supplementary Results, Supplementary Fig. 5 ).
To determine the non-cell-autonomous influence of unchallenged microglia on the astrocytic transcriptome, one can compare human reads within sample sets from 2a with those from 1a. As is illustrated (Fig. 2c) , very few astrocytic genes are altered (only 10). Nevertheless, one should still check if any one of them could be due to erroneous mapping, by mapping the human astrocyte-free neuron-microglia co-culture reads (sample set 3a) against the human genome (in this instance, none of the ten genes had a contribution from erroneous mapping from other species). As LPS-challenged microglia release factors that induce phenotypic and transcriptional changes in astrocytes 18 , we expected that the influence of LPS-challenged microglia on the astrocytic transcriptomes would be profound. To ascertain this, human reads within sample sets from 2b were compared with those from 1b. Note that it is important to compare samples with 1b, rather than 1a, to control for the direct influence that LPS has on astrocytes and distinguish this influence from that of microglia. As expected, a large number of genes were induced and repressed. Any genes arising because of potentially erroneous read mapping can be identified by mapping the human-astrocyte-free neuron-microglia co-culture reads (LPS-treated, 3b samples) against the human genome. In this instance, none of the (1,039) genes reported as induced (>1.5-fold increase in expression) and three of the 477 genes repressed (>1.5-fold decrease in expression) had a >10% contribution from erroneous mapping from other species and were as a consequence discarded from our scatter graph (Fig. 2d) . Genes induced in astrocytes by LPS-activated microglia include markers of neurotoxic 'A1'-type astrocytes C3 and MX1 (ref. 18 ; Fig. 2d ), as well as CHI3L1 and ICAM1, which are known to be aberrantly expressed by astrocytes in a range of neurodegenerative diseases 48, 49 . To determine the influence of unchallenged microglia on the neuronal transcriptome, reads from the 2a sample sets can be compared with those from 1a, but this time focusing on mouse reads (Fig. 2e) . No neuronal genes were found to be altered by unchallenged microglia (fold-change cutoff of 1.5-fold and an adjusted P value (false-discovery rate) of 0.05). To determine the influence that LPS-challenged microglia had on the neuronal transcriptome, mouse reads from 2b sample sets can be compared with those from 1b. As expected, this comparison revealed a large number of induced genes (Fig. 2f) . Controlling for erroneous mapping is achieved by mapping the neuron-free astrocyte-microglia co-culture reads (LPS-treated, 4b samples) against the mouse genome. This confirms very limited erroneous mapping: only 2 out of 430 induced genes and 0 of the 9 repressed genes had a >10% contribution from erroneous mapping from other species and so were discarded from our lists. Genes induced in neurons by LPS-activated microglia include the known interferonresponsive genes Oasl2, Isg15, Ifitm3, Timp1, and Stat2 (Fig. 2f) .
Thus, in the example application of the protocol just described, our approach simultaneously revealed the microglial response to LPS and the consequent influence of this microglial response on astrocytic and neuronal transcriptomes. Of note, LPS-activated microglia induce quite distinct transcriptional programs in neurons and astrocytes. If one takes the genes induced by microglia in astrocytes (Fig. 2d) and neurons (Fig. 2f) , and plots the fold change of those genes in the other cell type, it is clear that a relatively small number of genes are induced >1.5-fold in both cell types (Supplementary Fig. 6 ). To conclude, the mixed-species co-culture, followed by RNA-seq and Sargasso read separation, can be implemented to probe transcriptional profiles of neurons, astrocytes, and microglia within the same sample set, an approach that may be useful in answering questions surrounding cell-autonomous and non-autonomous signaling during development and in healthy and diseased states.
Reporting Summary
Further information on experimental design is available in the Life Sciences Reporting Summary.
